Jia Fan
Jia Fan leads one of the world's busiest liver cancer surgery and transplant programmes and the proteogenomic studies that mapped how hepatitis B-related liver cancer differs at the molecular level.
Overview
Liver surgeon and academician of the Chinese Academy of Sciences whose Liver Cancer Institute at Zhongshan Hospital performs thousands of resections and transplants a year; senior author of the integrated proteogenomic characterisation of HBV-related HCC (Cell 2019) and of work on circulating tumour cells, recurrence prediction and immune microenvironment; leads Chinese guidelines on HCC and on liver transplantation criteria.
| Title | Journal | Year |
|---|---|---|
| Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma | Cell | 2019 |
Pages like this
not linked directly; found by shared links- TrialORIENT-32
Shares Hepatitis B and C as cancer causes, Hepatocellular carcinoma and the tag china.
- InstitutionRenji Hospital, Shanghai Jiao Tong University
Shares Hepatocellular carcinoma and the tag china.
- TrialZGDH3 (donafenib vs sorafenib)
Shares Hepatocellular carcinoma and the tag china.
- PersonShukui Qin
Shares Hepatocellular carcinoma and the tag china.
- ProductDonafenib
Shares Hepatocellular carcinoma and the tag china.
- PersonZonghai Li
Shares Hepatocellular carcinoma and the tag china.
- ProductRivoceranib (apatinib)
Shares Hepatocellular carcinoma and the tag china.
- ProductSintilimab
Shares Hepatocellular carcinoma and the tag china.